Chromadex Corp CDXC:NASDAQ

Last Price$2.95NASDAQ Previous Close - Last Trade as of 3:59PM ET 3/27/20

Today's Change-0.05(1.67%)
Bid (Size)$2.96 (5)
Ask (Size)$3.16 (3)
Day Low / High$2.91 - 3.20
Volume385.9 K

View Chemicals: Specialty IndustryPeer Comparison as of 03/27/2020


Chromadex Corp ( NASDAQ )

Price: $2.95
Change: -0.05 (1.67%)
Volume: 385.9 K
3:59PM ET 3/27/2020

Green Plains Inc ( NASDAQ )

Price: $4.88
Change: -0.44 (8.27%)
Volume: 845.2 K
4:00PM ET 3/27/2020

Koppers Holdings Inc ( NYSE )

Price: $11.67
Change: -0.93 (7.38%)
Volume: 223.7 K
6:30PM ET 3/27/2020

AdvanSix Inc ( NYSE )

Price: $8.94
Change: -1.04 (10.42%)
Volume: 457.9 K
6:30PM ET 3/27/2020

Rayonier Advanced Materials Inc ( NYSE )

Price: $1.10
Change: -0.11 (9.09%)
Volume: 972.1 K
6:30PM ET 3/27/2020

Read more news Recent News

ChromaDex's 2021 Earnings Projection Cut
12:45AM ET 3/20/2020 MT Newswires

ChromaDex Corp's (NASDAQ:CDXC, Recent Price: 2.78) 2021 forecasted earnings estimate for the year ending December 31, 2021 has been scaled down. This...

MT Newswires After-Hours News Movers
5:56PM ET 3/10/2020 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: RESN, +20.59% DXC, +15.64% HEAR, +13.04% NCNA, +10.21% STNG, +8.42%...

ChromaDex Q4 Meets Expectations, Revenue Ahead - Stock Up Near 3% After-Hours
4:55PM ET 3/10/2020 MT Newswires

ChromaDex (CDXC) on Tuesday reported adjusted net loss of $0.11 per share in Q4, as expected in a Capital IQ survey. Revenue grew to $13.09 million from...

ChromaDex Starts New Line of High Purity Cannabinoid Reference Standards for Research
12:42PM ET 2/03/2020 MT Newswires

ChromaDex (CDXC), a provider of phytochemical reference standards and botanical reference materials, said on Monday it has expanded its reference standards...

Company Profile

Business DescriptionChromadex Corp. is a nutraceutical company. The firm engages in acquiring, developing and commercializing proprietary-based ingredient technologies. It operates through the following segments: Ingredients, Consumer Products, and Analytical Reference Standards and Services. The Ingredients segment offers NIAGEN in an ingredient form to partners. The Consumer Products segment sells TRU NIAGEN to improve health by safely raising NAD levels. The Analytical Reference Standards and Services segment provides product regulatory approval and scientific advisory services to the clients in the food, supplement, and pharmaceutical industries. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Los Angeles, CA. View company web site for more details
Address10900 Wilshire Boulevard
Los Angeles, California 90024
Number of Employees100
Recent SEC Filing03/24/2020CT ORDER
President, CEO, COO, DirectorRobert N. Fried
Chief Financial & Accounting OfficerKevin M. Farr
Vice President-Research & DevelopmentAron Erickson
Chief Technical OfficerBen Shichman

Company Highlights

Price Open$2.92
Previous Close$2.95
52 Week Range$2.50 - 4.95
Market Capitalization$176.4 M
Shares Outstanding59.8 M
SectorProcess Industries
IndustryChemicals: Specialty
Next Earnings Announcement05/14/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.54
Beta vs. S&P 500N/A
Revenue$31.6 M
Net Profit Margin-69.45%
Return on Equity-153.61%

Analyst Ratings as of 01/10/2020

Consensus RecommendationConsensus Icon
Powered by Factset